Back to search
Adamantinomatous Craniopharyngioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adamantinomatous Craniopharyngioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Adamantinomatous Craniopharyngioma trials you may qualify forThe goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) Ju…
MEKTOVI (binimetinib) is an oral, highly selective reversible inhibitor of mitogen-activated extracellular signal regulated kinase 1 (MEK1) and MEK2. The biolog…